NOVN Novartis AG
118.38CHF+1.63%Mkt Cap: 252.68B $P/E: 22.19Today
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to tre…
Industry Peers
Drug Manufacturers - GeneralKey Statistics
Company
Market Cap252.68B USD
Enterprise Value300.08B USD
Revenue (TTM)64.70B USD
Gross Profit49.05B USD
Net Income (TTM)15.96B USD
Revenue/Share29.64 CHF
Last Price118.38 CHF
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees75.3K
CountryCH
SectorHealthcare
IndustryDrug Manufacturers - General
ISINCH0012005267
Valuation
P/E (Trailing)22.19
P/E (Forward)14.18
PEG3.26
EV/EBITDA11.38
EV/Revenue4.64
P/S3.90
P/B6.45
EPS (TTM)5.25
EPS (Forward)8.20
52W Range
97.0560% of range132.68
52W High132.68 CHF
52W Low97.05 CHF
Profitability
Gross Margin75.83%
Oper. Margin34.62%
EBITDA Margin40.74%
Profit Margin24.67%
ROE30.31%
ROA12.60%
Growth
Revenue Growth0.80%
Earnings Growth-17.00%
Cash Flow & Leverage
Operating CF21.85B USD
CapEx (TTM)4.45B USD
FCF Margin20.99%
FCF Yield5.38%
Net Debt47.25B USD
Net Debt/EBITDA1.79
Balance Sheet
Debt/Equity0.77
Current Ratio0.86
Quick Ratio0.55
Book Value/Sh18.04 CHF
Cash/Share4.01 CHF
Dividends
Fwd Div Rate3.70 CHF
Trail. Div Rate4.67 CHF
Div. Yield3.18%
5Y Avg Yield3.53%
Payout Ratio68.92%
Ex-Div DateMar 10, 2026
Pay DateMar 13, 2025
Splits
Last Split40:1
Split DateMay 7, 2001
Analyst Consensus
Rating2.7 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)125.78 CHF
Upside (mean)+6.3%
Target Range100.38 CHF – 151.04 CHF
100.38+6.3% to mean151.04
# Analysts22
Ownership
Shares Out.1.90B
Float1.86B
Insiders2.11%
Institutions46.04%
Technical
SMA 50122.57 (-3.4%)
SMA 200120.39 (-1.7%)
Beta0.49
S&P 52W Chg14.58%
Avg Vol (30d)3.41M
Avg Vol (10d)3.02M
Technical Indicators
RSI (14)42.2
MACD-1.0867
MACD Signal-1.3897
MACD Hist.+0.3030
BB Upper122.29 CHF
BB Middle116.15 CHF
BB Lower110.01 CHF
BB Width10.57%
ATR (14)2.603 CHF
Vol Ratio (20d)0.63x